Insider Trading & Executive Data
Start Free Trial
6 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
HeartCore Enterprises (HTCR) is a Tokyo‑based enterprise software company with two principal lines: a multi‑tenant CXM SaaS platform (marketing, sales, service and content management) sold on a freemium‑to‑subscription model and a digital transformation (DX) practice focused on intelligent process automation (RPA, task/process mining and AI computer vision). The company also offers GO IPO consulting for Japanese issuers seeking U.S. listings, which materially boosted 2024 revenue; 2024 revenue was $30.4M (up 39.2%) with 982 total CXM/DX customers (724 paying) and ~25.8% of revenue from U.S. customers. Go‑to‑market is a mix of direct sales and channel partners (system integrators/VARs/cloud vendors) that drive a large share of Japanese customers (~62%) and revenue (~50%); operational footprint includes subsidiaries in the U.S. (Sigmaways) and Vietnam (HeartCore Luvina). Key operational dependencies include major cloud providers, partner ecosystem health, exposure to cross‑border data/privacy regulations, and limited patent protection.
Given HeartCore’s subscription/usage business and the recent prominence of GO IPO consulting and license sales, executive pay is likely tied to recurring revenue metrics (ARR/renewal and upsell rates), large license order/booking milestones, and successful monetization of consultancy engagements (which can produce noncash warrants/shares). Management has already reduced stock‑based compensation as a cost control lever, so compensation packages may tilt toward cash bonuses, milestone‑based awards, and performance‑contingent equity (including warrants or restricted shares) tied to financings, Nasdaq compliance milestones, or successful IPO client outcomes. The company’s use of noncash consideration (valued with Black‑Scholes/binomial models) and the material impact of impairment tests introduce subjectivity that can affect reported results and bonus payouts; boards may therefore include non‑GAAP or adjusted metrics to limit volatility in incentive pay. Recent financing actions (Series A convertible preferred with 10% dividends, equity line up to $25M, commitment shares) increase potential dilution and create scenarios where compensation committees need to balance retention with shareholder dilution concerns.
Insider trading patterns at HeartCore may cluster around several company‑specific events: recognition of noncash consideration from GO IPO clients (which materially affects reported revenue and margins), large on‑premise license bookings, financings/issuances (Series A, equity line, commitment shares), and Nasdaq compliance actions (reverse split proposals or cure periods). Because a single customer represented >10% of 2024 revenue and U.S. customers account for a meaningful share, insiders may trade around material customer wins/losses or cross‑border regulatory developments that affect revenue visibility. Expect heightened use of trading restrictions, blackout windows around earnings and financing announcements, and likely adoption of 10b5‑1 plans for executives to avoid appearance of trading on material nonpublic information; related‑party exposures from Sigmaways and HeartCore Luvina also warrant monitoring for affiliated transactions.